# Intraosseous Infusion in Hematologic Critical Patients

> **NCT07239375** · — · RECRUITING · sponsor: **Shanxi Bethune Hospital** · enrollment: 52 (estimated)

## Conditions studied

- Intraosseous Infusions

## Interventions

- **DEVICE:** intra-osseous (IO) infusion needle/catheter

## Key facts

- **NCT ID:** NCT07239375
- **Lead sponsor:** Shanxi Bethune Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-22
- **Primary completion:** 2027-10-22
- **Final completion:** 2027-10-23
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07239375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07239375, "Intraosseous Infusion in Hematologic Critical Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07239375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*